Why central weight is metabolic, not a willpower failure
If weight settles around your midsection and resists every effort to shift it, the issue is frequently chemistry, not discipline. Fat stored deep in the abdomen, called visceral fat, behaves like an active organ. It releases free fatty acids and inflammatory signals that interfere with how insulin works, which makes it harder for the body to clear sugar from the blood and easier to store more fat centrally.
This is a loop, not a character flaw. The more insulin resistance builds, the more the body leans on rising insulin levels, and insulin is a fat-storage hormone. Telling someone in that loop to simply eat less misreads the biology and adds shame on top of a medical problem.
For Black women, the picture has a specific twist worth knowing. Research comparing Black and white women found that Black women often have lower visceral and liver fat yet show greater insulin resistance and a higher risk of type 2 diabetes. In practice that means a clinician cannot rule out a metabolic problem just because imaging or a waistline looks reassuring. The risk can be present even when the usual visual cues are not.
Insulin resistance, explained plainly
Insulin is the hormone that lets your cells take in glucose for energy. Insulin resistance means the cells stop responding the way they should, so the pancreas pumps out more insulin to compensate. For a while, blood sugar stays normal because the extra insulin is doing the work behind the scenes. That is exactly why it is so easy to miss: most people with insulin resistance and prediabetes have no symptoms at all.
Left unaddressed, the pattern can progress toward prediabetes and then type 2 diabetes. The recognized risk factors include carrying extra weight, a large waist size, being age 35 or older, a history of gestational diabetes, and conditions such as PCOS. If any of these apply to you, insulin resistance is worth checking for directly rather than waiting for symptoms that may never arrive until damage is done. Learn more in our guide to type 2 diabetes.
PCOS in Black women: common, under-recognized, and metabolic
Polycystic ovary syndrome is one of the most common hormonal conditions in women of reproductive age, and insulin resistance sits near the center of it. PCOS is diagnosed using the Rotterdam criteria, which require two of three findings: signs of excess androgens, irregular or absent ovulation, and polycystic ovaries on ultrasound, after other causes are excluded. It commonly shows up as irregular periods, difficulty losing weight, acne, and unwanted hair growth.
The diagnostic gap for Black women is real and documented. In analyses of how PCOS is identified, the women referred for specialist evaluation skew heavily white, while Black women are far more represented in unselected community screening, a pattern consistent with referral bias and under-diagnosis. At the same time, Black women with PCOS tend to show higher fasting insulin, higher HOMA-IR insulin-resistance scores, and a markedly higher incidence of metabolic syndrome than white women with PCOS. The condition is not milder in Black women. It is more likely to be metabolically serious and less likely to be caught early.
Treatment is grounded in lowering insulin resistance: lifestyle change, metformin, and hormonal options chosen for your goals, whether that is regular cycles, fertility, or symptom control. If your periods are irregular and the scale will not move, ask specifically about PCOS. Our polycystic ovary syndrome condition page walks through symptoms and care options in detail.
Acanthosis nigricans: a visible clue you can see in the mirror
One of the most useful signs of high insulin is something you can spot yourself. Acanthosis nigricans is a darkened, thickened, velvety patch of skin that most often appears on the back of the neck, in the armpits, or over the knuckles. It is recognized as a condition associated with insulin resistance. In studies, people with acanthosis nigricans had measurably higher insulin and HOMA-IR levels, and examining the neck and underarms is described as a noninvasive, low-cost way to flag people who may already have insulin resistance.
On brown and Black skin this can be mistaken for dirt, friction, or a hygiene issue, and it is none of those. It is a metabolic flag. If you have it, treat it as a prompt to get your insulin and blood sugar checked, not a cosmetic concern to scrub away. We cover what it looks like and what to do about it in acanthosis nigricans and a dark neck on Black skin.
Metabolic syndrome: when the risks cluster
Central weight rarely travels alone. Metabolic syndrome is a recognized cluster diagnosed when at least three of five findings are present: a larger waist circumference (88 cm or more in women), elevated triglycerides, low HDL cholesterol, raised blood pressure, and elevated fasting glucose. The cluster matters because each piece amplifies the others and together they raise the risk of diabetes and heart disease.
For Black women this is one more reason not to rely on a single number. Triglycerides can read deceptively normal in Black women even when insulin resistance is present, which means the standard metabolic-syndrome screen can underestimate risk if a clinician treats normal triglycerides as all-clear. The takeaway is to look at the full panel and the personal risk picture, not one reassuring lab value.
What actually helps (the sustainable version)
Crash diets fail because they fight the same hormonal system that is already dysregulated, and the weight returns. The strongest evidence points toward steady, maintainable change. In the Diabetes Prevention Program, participants who aimed for 7 percent weight loss and 150 minutes of weekly activity comparable to brisk walking lowered their risk of developing type 2 diabetes by 58 percent, and the benefit held across every racial and ethnic group studied. That is a modest, reachable target with an outsized payoff.
What that looks like in practice:
- Build meals around protein, fiber, and whole foods that blunt blood-sugar spikes, rather than chasing extreme restriction.
- Move most days. Walking counts. Resistance training helps muscle take up glucose, which directly improves insulin sensitivity.
- Prioritize sleep and stress load. Both shift the hormones that govern appetite and insulin.
- Treat the underlying condition. If PCOS or insulin resistance is confirmed, metformin or other medications address the root, not just the number on the scale.
None of this is about willpower or shrinking yourself. It is about lowering insulin resistance so your body stops working against you.
Where GLP-1 medication fits
When lifestyle change is not enough on its own, GLP-1 based medications have changed what is possible. In the STEP 1 trial, once-weekly semaglutide produced an average weight loss of 14.9 percent over 68 weeks versus 2.4 percent on placebo. The dual-agonist tirzepatide went further in SURMOUNT-1, with average reductions of 15.0 to 20.9 percent across doses versus 3.1 percent on placebo. A head-to-head trial, SURMOUNT-5, found tirzepatide led to greater weight loss than semaglutide, 20.2 percent versus 13.7 percent over 72 weeks.
These medications are especially relevant when insulin resistance, PCOS, or metabolic syndrome is part of the picture, because they target appetite and metabolic signaling rather than asking you to out-discipline your biology. They are a legitimate medical tool, not a shortcut or a failure. Access, cost, and clinical fit vary, and they work best alongside the same nutrition and movement habits above. See our online GLP-1 care overview to understand how evaluation and prescribing typically work.
Tests to ask for
You do not have to wait for symptoms. Bring this list to your appointment and ask your clinician which are right for you:
- Fasting glucose and HbA1c, to screen for prediabetes and diabetes.
- Fasting insulin (and a HOMA-IR calculation), to detect insulin resistance before blood sugar rises.
- A lipid panel including triglycerides and HDL, part of the metabolic-syndrome workup, with the caveat that normal triglycerides do not rule out risk in Black women.
- Blood pressure and waist circumference, the other metabolic-syndrome components.
- If periods are irregular or you have acne or excess hair growth, ask about a PCOS evaluation, which may include androgen levels, a glucose tolerance test, and a pelvic ultrasound.
If you have acanthosis nigricans, point it out directly and ask for insulin and glucose testing. It is one of the clearest visible reasons to look. You can also find a clinician in our directory who specializes in caring for Black communities.
Frequently asked questions
Why can't I lose belly fat even when I eat less? ▼
Because central weight is often driven by insulin resistance, a hormonal state where high insulin promotes fat storage and resists fat loss. It frequently produces no symptoms, so the underlying cause goes untreated while diets fail. Testing for insulin resistance and treating the root cause works better than further restriction.
Does PCOS cause weight gain around the stomach? ▼
PCOS is closely tied to insulin resistance, which promotes central weight gain and makes weight loss harder. PCOS is also under-diagnosed in Black women despite often more severe metabolic dysfunction, so irregular periods plus stubborn belly weight is worth a specific PCOS evaluation.
Is a dark patch on my neck a sign of a problem? ▼
It can be. A darkened, velvety patch on the neck, armpits, or knuckles is acanthosis nigricans, a skin marker associated with high insulin and insulin resistance. It is not a hygiene issue and is a reason to get your insulin and blood sugar tested.
Do GLP-1 medications actually work for metabolic weight? ▼
Yes. In randomized trials, semaglutide produced about 15 percent average weight loss and tirzepatide produced up to roughly 21 percent, both far above placebo, and a head-to-head trial favored tirzepatide. They target the metabolic and appetite pathways rather than relying on willpower.